We come to In-Cosmetics for the second time to share the benefits of high resolution skin imaging, a powerful alternative to punch biopsy. Contact us to schedule a meeting. In-Cosmetics is one of the leading exhibitions in the cosmetics industry.
Schedule a meeting with Leonard Khiroug (CSO) and Ilya Kirilkin (Product Development Manager) or visit our poster on “Quantification of the pharmacokinetics of IgG penetration through blood-brain barrier (trans-BBB PK) with in vivo two-photon microscopy”. Antibody Biology and Engineering is one of the Gordon Research Conferences.
This year, Neurotar will feature its proprietary research devices and the new types of research that they enable. Katja Karelina (CEO) and Leonard Khiroug (CSO) are happy to talk to investors about our plans to grow the company, and to partners interested in advancing their biologics’ development through in vivo two-photon imaging –based screening. We […] Read more »
Leonard Khirug (CSO) presents Skinvivo service offering for cosmetic product development with an emphasis on the newly developed readout — measuring advanced glycation end-products (AGE) in the skin of human volunteers.
The lecture features Neurotar’s proprietary Mobile HomeCage device, which enables imaging in awake and freely moving animals. Leonard Khiroug (CSO) shares the experiences of using the device for in vivo two-photon imaging and maps out other application areas.
Slush is the largest start-up conference in Northern Europe and Russia. It is held in Helsinki. This year, 1000 companies and 500 investors are expected to participate. To schedule a meeting with Neurotar’s CEO, Katja Karelina, please follow this link https://meetin.gs/meet/katja-karelina1 or send a direct mail through the contact page.
Neurotar team comes to San Diego for partnering and client meeting in the Bay area. The team attends Society for Neuroscience meeting with an aim of promoting the Mobile HomeCage, Neurotar’s proprietary research device for imaging in awake and freely moving mice. The device is due to be launched before the end of the year. […] Read more »
Neurotar first entered the market for research services in cosmetics in 2012. Since then, our cosmetics service offering (Skinvivo services) has grown far beyond the original best-sellers, repetitive high resolution measurements of changes in collagen’s and elastin’s amounts and fine structure in the living human skin. We have since developed readouts for measuring the redox […] Read more »
On July 16, 2013, the US Patent and Trademark Office granted a patent for Neurotar’s mobile platform (Mobile HomeCage) for awake animal imaging (US 8,485,133). EU patent is pending. Neurotar’s scientists continue to work with the current prototype to optimize services, which will be available to our customers at the end of 2013. Development of two […] Read more »
Neurotar’s SCO, Leonard Khirug, attends Eurotox congress in Interlaken, Switzerland, on Spetember 1.-3., 2013 to promote Neurotar’s new safety assessment assay for CNS and non-CNS drugs.